[Oral antidiabetic drugs].
D000284:Administration, Oral; D002318:Cardiovascular Diseases / Q000139:chemically induced; D003920:Diabetes Mellitus / Q000188:drug therapy; D004341:Drug Evaluation; D006801:Humans; D013453:Sulfonylurea Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D014044:Tolbutamide / Q000009:adverse effects* / Q000627:therapeutic use
D013453:Sulfonylurea Compounds; D014044:Tolbutamide
Orale Antidiabetika